Vertaling van "dealt with in these meetings " (Nederlands → Frans) :

The cases dealt with in these meetings may be complaints by consumers or producers, requests for advice from inspection services, formal opinions on the formulation of regulations, formal opinions for companies wishing to market products and to ensure that they are presenting their product correctly, and internal cases that serve for the compilation of guidelines for the consultation platform.
The cases dealt with in these meetings may be complaints by consumers or producers, requests for advice from inspection services, formal opinions on the formulation of regulations, formal opinions for companies wishing to market products and to ensure that they are presenting their product correctly, and internal cases that serve for the compilation of guidelines for the consultation platform.

The commission for the supervision of advertising of medicines for human use dealt with 61 approval applications for radio/TV advertising during 16 meetings
The commission for the supervision of advertising of medicines for human use dealt with 61 approval applications for radio/TV advertising during 16 meetings

The goal is to achieve a consensus on how these highrisk patients should be dealt with.
On veut arriver à un consensus sur la prise en charge des patients à risque.

Moreover, the BfR (2008) argues that these beverages need to be dealt with in a standardised way on a European level.
En outre, le BfR (2008) plaide pour une approche standardisée de ces boissons au niveau européen.

AIN457 Non-infectious uveitis 2011 III - Phase III study examining AIN457 for non-infectious uveitis in patients with Behcet’s disease did not meet its primary endpoint and the data do not support submission of AIN457 for this indication; based upon analysis of these data, Novartis will stop the extension study in Behcet’s uveitis
Indication potentielle/ Projet / domaine Soumissions Phase Mises à jour molécule thérapeutique prévues actuelle AIN457 Uveitis non infectieuse 2011 III - L’étude de phase III examinant AIN457 contre l’uveitis non infectieuse chez les patients atteints de la maladie de Behcet n’a pas satisfait au critère principal et les résultats sont insuffisants pour justifier le dépôt d’une demande d’autorisation pour cette indication, Novartis arrêtera l’extension de cette étude à l’uveitis de Behcet